Assertio Therapeutics Announces Third-Quarter 2019 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. NVDA
7. CRBU
8. BBIO
9. RCKT
10. OPCH

Go back to Assertio Therapeutics Announces Third-Quarter 2019 Results

Assertio Therapeutics (ASRT) Reports In-Line Q3 EPS; Raises Outlook

November 6, 2019 5:15 PM EST

Assertio Therapeutics (NASDAQ: ASRT) reported Q3 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $55.1 million versus the consensus estimate of $60.74 million.

We reported another quarter of strong earnings growth, exceeding non-GAAP adjusted EBITDA expectations... More